Chronic obstructive pulmonary disease (COPD) is linked to both cigarette smoking and genetic determinants. We have previously identified iron-responsive element-binding protein 2 (IRP2) as an important COPD susceptibility gene and have shown that IRP2 protein is increased in the lungs of individuals with COPD. Here we demonstrate that mice deficient in Irp2 were protected from cigarette smoke (CS)-induced experimental COPD. By integrating RNA immunoprecipitation followed by sequencing (RIP-seq), RNA sequencing (RNA-seq), and gene expression and functional enrichment clustering analysis, we identified Irp2 as a regulator of mitochondrial function in the lungs of mice. Irp2 increased mitochondrial iron loading and levels of cytochrome c oxidase (COX), which led to mitochondrial dysfunction and subsequent experimental COPD. Frataxin-deficient mice, which had higher mitochondrial iron loading, showed impaired airway mucociliary clearance (MCC) and higher pulmonary inflammation at baseline, whereas mice deficient in the synthesis of cytochrome c oxidase, which have reduced COX, were protected from CS-induced pulmonary inflammation and impairment of MCC. Mice treated with a mitochondrial iron chelator or mice fed a low-iron diet were protected from CS-induced COPD. Mitochondrial iron chelation also alleviated CS-induced impairment of MCC, CS-induced pulmonary inflammation and CS-associated lung injury in mice with established COPD, suggesting a critical functional role and potential therapeutic intervention for the mitochondrial-iron axis in COPD.
COPD presents as a complex, debilitating lung disease that encompasses a variety of clinical and pathologic phenotypes ranging from airway inflammation (chronic bronchitis) to destruction of lung tissue (emphysema) and remodeling of the small airways 1, 2 . The pathogenesis of COPD remains poorly understood, but it involves aberrant inflammatory and dysregulated cellular responses of the lung to CS exposure 1 .
CS exposure remains the greatest environmental risk factor for COPD; however, multiple studies have suggested that genetic factors also influence COPD susceptibility 3 . We previously identified IRP2 (also known as IREB2) as a leading candidate COPD susceptibility gene [4] [5] [6] in humans on the basis of genome-wide association studies (GWAS), and we demonstrated that IRP2 protein is increased in the lungs of subjects with COPD 4 . IRP2 is located within a cluster of genes on human chromosome 15q25, which includes genes that encode several components of the nicotinic acetylcholine receptor. In addition to COPD, 15q25 has been associated with lung cancer, peripheral arterial disease and nicotine addiction in GWAS [7] [8] [9] [10] .
The iron-regulatory proteins (IRPs) IRP1 and IRP2 regulate cellular iron homeostasis, with IRP2 serving as the major regulatory protein in mammalian cells 11 . IRPs have important physiological roles in the duodenum, spinal cord and central nervous system, and in the pathogenesis of pulmonary hypertension and neurodegenerative diseases [12] [13] [14] [15] . In the setting of iron depletion, IRPs decrease iron storage and increase iron uptake by binding to iron-response elements (IREs) located in the mRNAs of genes involved in iron homeostasis, which results in translational repression or stabilization of the transcripts 12, 15 . The critical physiological function of IRP2 in the lung and the mRNA transcripts targeted by IRP2 are not well known, nor is it clear whether IRP2 has a role in the response of the lung to CS exposure or in the pathogenesis of CS-induced COPD.
Here we sought to delineate the function of the COPD susceptibility gene IRP2 in the pathogenesis of CS-induced COPD by integrating human COPD expression data with experimental mouse models of COPD. Our studies are the first to characterize a functional role for Irp2 in the lung, wherein Irp2 promotes mitochondrial dysfunction in experimental COPD by regulating mitochondrial iron loading and cytochrome c oxidase. Notably, we also show that mitochondrial iron chelation using the siderophore deferiprone alleviates established disease in a model of CS-induced pulmonary inflammation and injury (experimental COPD), highlighting a potential novel therapeutic approach for COPD.
RESULTS

Irp2-deficient mice resist experimental COPD
To characterize the functional role of IRP2 in the pathogenesis of COPD, we used two well-established experimental models of CS-induced COPD, namely CS-induced emphysema (4-to 6-month exposure) 16, 17 and CS-induced impairment of MCC (1-month exposure) 17, 18 . MCC, which is characterized by the upward movement of mucus by ciliary motion, can be impaired by airway-cell dysfunction 19 or infiltration of immune cells into the lung 20 . Impaired MCC leads to excessive airway mucus, recurrent pulmonary infection and chronic bronchitis 1 .
Consistent with our observations from the lungs of human subjects with COPD 4 , we observed higher Irp2 expression (with no change in Irp1 expression) and activity in the lungs of wild-type (WT) mice exposed to CS for 1-6 months as compared to room air (RA)-exposed controls (Fig. 1a-c) . Irp2 expression was localized in lung epithelial cells, including type I alveolar (podoplanin-positive), type II alveolar (prosurfactant protein C (SPC)-positive), secretory airway (uteroglobinpositive) and ciliated airway (acetylated α-tubulin-positive) cells ( Fig. 1d and Supplementary Fig. 1a,b) , as assessed by immunohistochemical analyses. Irp2 expression also seemed to localize to the walls of intermediate-size vessels, with negligible staining in basal (cytokeratin 5-positive) epithelial cells ( Supplementary Fig. 1b ). Irp2 expression was higher in type I, type II, secretory and ciliated epithelial cells, as well as in infiltrating alveolar macrophages in response to CS (6-month exposure), as compared to RA controls ( Fig. 1d and Supplementary Fig. 1a,b) . We also observed higher Irp2 expression after aqueous cigarette-smoke extract (CSE) treatment (an in vitro model of CS exposure) in primary human bronchial airway epithelial cells and in the human bronchial airway epithelial cell line Beas2B, as compared to RA-exposed controls (Supplementary Fig. 1c,d) .
Overexpression of Irp2 has been associated with embryonic lethality in mice 21 ; we therefore used a loss-of-function approach to study the function of Irp2 in experimental COPD. WT mice exposed to CS for 4-6 months had increased mean chord lengths and air-space diameters ( Fig. 1d and Supplementary Fig. 2a) , and showed greater thickness of the small airways (all established indices of experimental COPD 2, 17 ) , as compared to RA-exposed WT mice (Fig. 1e) . Irp2 −/− mice resisted CS-induced changes in mean chord length and air-space diameter and were protected from small-airway remodeling (Fig. 1e,f and Supplementary Fig. 2a ). Irp2 −/− mice were also protected from the expression of CS-induced injury markers previously shown to be associated with emphysema, including cleaved caspase-3 (indicating increased apoptosis) 22 , matrix metalloproteinase 9 (MMP9) 23 expression and the autophagy markers LC3B 17 and Atg7 ( Fig. 1g and Supplementary Fig. 2b,c) . Irp1 expression did not change in RA-or CS-exposed Irp2 −/− mice (Supplementary Fig. 2d ).
We have recently developed an experimental model of CS-induced bronchitis by exposing mice acutely to CS (1-month exposure) and measuring MCC 17, 18 (Fig. 1h ). In this model, bronchoalveolar lavage (BAL) fluid (BALF) from CS-exposed WT mice had greater leukocyte counts and greater total BALF protein levels (an indicator of increased epithelial cell injury and permeability 24 ) than RA-exposed WT mice ( Supplementary Fig. 2e,f) . CS-exposed mice also had higher concentrations of BALF interleukin (IL)-33 (a pleiotropic cytokine predominantly expressed in lung tissue that induces airway inflammation in naive mice 25 ) and BALF IL-6 (a cytokine associated with the severity of acute COPD exacerbations and decline in lung function 26 ) than RA-exposed WT mice (Fig. 1i ). Using this model, the MCC of WT lungs exposed to CS was significantly lower than that of RA-exposed controls (P < 0.05) ( Fig. 1h) . Irp2 −/− mice were protected from CS-impaired MCC, and CS-exposed Irp2 −/− mice exhibited less BALF IL-6 and IL-33 than CS-exposed WT mice ( Fig. 1h,i) . Irp2 deficiency failed to protect against lung injury (with increased numbers of BAL leukocytes and increased levels of BALF protein and BAL IL-6 and IL-33 protein) and mortality in a hyperoxia-induced acute lung injury mouse model and in a cecal ligation and puncture-induced polymicrobial sepsis mouse model ( Supplementary Fig. 3a-g) , highlighting the specificity of the functional role of IRP2 in CS-induced lung injury associated with COPD.
Identification of novel target pathways of IRP2 in the lung As described above, Irp2 conferred important functional impacts in the pathogenesis of COPD in two experimental COPD models. We therefore sought to delineate the mechanism by which Irp2 promoted experimental COPD by first identifying the downstream targets of IRP2 in the lung. For unbiased identification of RNA targets of IRP2, we used the human airway epithelial cell line Beas2B, either stimulated with deferoxamine (DFO) (to stabilize IRP2 expression 27 ) or left unstimulated, immunoprecipitated IRP2-RNA complexes and performed whole-transcriptome sequencing (RIP-seq) ( Supplementary  Fig. 4a-c) . This analysis identified 1,806 IRP2-related target genes, which included transcripts for known IRP2 targets, such as ferritin and the transferrin receptor (TfR) ( Supplementary Fig. 4d-f) , thus validating the model system.
To better understand the biological meaning behind the IRP2 target genes, we used functional enrichment clustering analysis (see Online Methods and Supplementary Fig. 4g ) and identified five core functional 'communities' or pathways (depicted as word clouds), as demonstrated by the Circos plot in Figure 2a . On this plot, the differential expression of genes in the lung tissue of individuals with COPD (from the Lung Genomics Research Consortium (LGRC)), as compared to that of healthy controls (black ring), is also shown ( Fig. 2a ). We observed that many of the genes in each of the five communities had altered expression in subjects with COPD and were known to be involved in the progression or pathogenesis of COPD ( Supplementary Table 1 ).
To associate this human data to the heterogeneous in vivo environment of the lung in the absence of IRP2, we evaluated each of the five RIP-seq-derived communities for differential expression patterns using a microarray study of lungs from WT and Irp2 −/− mice (Fig. 2b) . a r t i c l e s nature medicine VOLUME 22 | NUMBER 2 | FEBRUARY 2016 1 6 5
This analysis identified one community, community 2, as having the most significant differential expression of genes between the Irp2 −/− and WT mice ( Fig. 2c ) (P = 1.08 × 10 −8 ). Gene Ontology database analysis of the differentially expressed genes associated with community 2 ( Fig. 3a and Supplementary Fig. 5 ) showed that one of the main pathways to emerge was related to mitochondrial function.
To assess the relationship between the differentially expressed mitochondrial genes ( Fig. 3a) and IRP2 expression in human subjects with COPD, we evaluated the expression pattern of these genes in individuals with COPD and in control individuals with high or low IRP2 expression using two human COPD cohorts, namely the LGRC (gene expression in lung tissue) and ECLIPSE ('evaluation of COPD longitudinally to identify predictive surrogate end points'; gene expression in blood) cohorts. A strong association between the differential expression of mitochondrial genes and differences in IRP2 expression were observed, with an overall stronger association observed in subjects with COPD (Fig. 3b,c and Supplementary Fig. 6 ).
Irp2 −/− mice resist CS-induced mitochondrial dysfunction
On the basis of the functional pathways highlighted in the RIP-seq and differential-expression analyses from mice and humans, we assessed the functional role of IRP2 in mitochondrial responses to CS in experimental COPD. We found that lung epithelial cells from WT mice exposed to CS had abnormal mitochondrial morphology, with evidence of cristae loss and mitochondrial swelling ( Fig. 3d) . Irp2 −/− mice had higher levels of abnormal mitochondrial morphology at baseline, as compared to WT controls, and in response to CS, Irp2 −/− mouse airway cells developed fewer mitochondria with abnormal morphology (Fig. 3d) . Immunohistochemical staining for cytosolic cytochrome c, a marker of mitochondrial damage 28 , demonstrated that CS-induced mitochondrial damage localized to alveolar and WT Irp2
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RA CS ** ** ** ** ** Figure 1 Irp2 is pathogenic in experimental COPD. (a) Quantification of Irp2 protein in WT mouse lungs exposed to room air (RA) or CS (1-6 months) (left) and Irp2 mRNA (at 6 months; right) levels (n = 8 per group). (b) Representative (n = 4) electrophoretic mobility shift assay (EMSA) (left) and quantification (middle and right) of total Irp (middle; n = 5 per group) or Irp2 (right; n = 3 per group) activity. (c) Irp1 protein expression in WT mouse lungs exposed to RA or CS (1-6 months) (n = 3 per group). (d) Representative micrographs for Irp2 immunostaining (arrows indicate Irp2) in WT mouse lungs exposed to RA (top) or CS (bottom) for 1-6 months. Lower-magnification images (left) and higher-magnification images of boxed areas (right) are shown. Scale bars, 50 µm. (e) Left, representative H&E-stained lung sections (n = 3 mice per group) of WT (top) and Irp2 −/− (bottom) mice exposed to RA (left) or CS (right) for 6 months. Scale bars, 50 µm. Middle and right, quantification of mean chord length L m (middle) and weighted mean diameters (right) of RA-or CS-exposed (6 months) WT and Irp2 −/− mice. (f) Left, representative micrographs (n = 2 technical replicates) of trichromestained lung sections from WT (top) and Irp2 −/− (bottom) mice exposed to RA (left) or CS (right). Scale bars, 50 µm. Right, quantification of the thickness of extracellular matrix (ECM) protein around the small airways in WT and Irp2 −/− mice exposed to RA or CS for 6 months. (g) Quantification of cleaved caspase-3 (picograms of cleaved caspase-3 per milliliter per milligram of lung tissue) (n = 7 per group) (left) and MMP-9 (WT: RA, n = 5: CS, n = 3; Irp2 −/− : RA, n = 6; CS, n = 6) (right) levels in whole lungs of WT and Irp2 −/− mice exposed to RA or CS for 6 months, using ELISA (n = 2 technical replicates). (h) 99m Tc-sc clearance over 1-3 h (left) in WT mouse lungs exposed to RA (n = 9) or CS (n = 10) for 1 month. 3 h 99m Tc-sc clearance (right), (i) BALF IL-33 (left, ELISA; WTRA n = 3; WTCS n = 5; Irp2 −/− RA n = 5; Irp2 −/− C n = 6) and BALF IL-6 protein concentrations (right, ELISA, n = 3 per group) in WT and Irp2 −/− mice exposed to RA or CS (1 month). Throughout, data are mean ± s.e.m. *P < 0.05, **P < 0.01 by one-way analysis of variance (ANOVA) with Bonferroni correction; # P < 0.05, ## P < 0.01, ### P < 0.005 by Student's unpaired t-test; n.s., not significant. npg airway epithelial cells in WT mice. Irp2 −/− mice, however, exhibited negligible staining for cytosolic cytochrome c in airway or alveolar epithelial cells after CS exposure ( Fig. 3e and Supplementary Fig. 7) .
Mitochondria isolated from whole-lung homogenates of CS-exposed WT mice had lower membrane potential (∆Ψ), as indicated by uptake of JC1, a dye that exhibits potential-dependent accumulation in healthy mitochondria, than did those from RA-exposed controls ( Fig. 3f) . Mitochondria isolated from whole-lung homogenates of Irp2 −/− mice were protected from CS-induced decreases in ∆Ψ ( Fig. 3f) . Similarly, as compared to WT cells, primary lung epithelial cells isolated from Irp2 −/− mice were resistant to CSE-induced mitochondrial depolarization, as measured by staining with tetramethylrhodamine ethyl ester (TMRE), a cell-permeant, positively charged dye that readily accumulates in active mitochondria due to their a RIP-seq of IRP2 target RNA in human epithelial cells 
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DAVID to identify GO terms
Meta-t-statistic to evaluate collective differential expression of genes in communities Figure 2 Novel targets of IRP2 in the lung. (a) Circos plot of communities of genes and GO terms to demonstrate gene transcripts and pathways enriched and/or altered in the RIP-seq data set. Control (Ctl)-specific (blue), DFO-specific (red) and common (purple) peak data sets are represented by individual rings, with the height of the bars corresponding to the peak score (n = 2 biological replicates). Gene expression data (mRNA) from the LGRC (n = 121 subjects with COPD; n = 20 non-smokers; n = 18 smokers) are represented on the inner black ring. The height of these bars corresponds to the log 2 fold change (FC) in gene expression levels between subjects with COPD and controls. Green denotes lower, and magenta denotes higher, expression in individuals with COPD. Word clouds represent GO terms in each community, with the size of each word reflecting its frequency among the names of the pathways in the community. Community 1 shows enrichment for genes involved in the cell cycle, the metabolism of RNA, the proteasome and the immune system. Community 2 shows enrichment for genes involved in metabolism, mitochondria and membrane trafficking. Community 3 shows enrichment for genes involved in DNA repair, apoptosis, the cell cycle and signal transduction. Community 4 shows enrichment for genes involved in the metabolism of proteins, transcription and translation. Community 5 shows enrichment for genes involved in nucleotide and purine metabolism pathways. z-score RA CS npg relative negative charge ( Fig. 3g) . Human airway epithelial cells deficient in IRP2 (as a result of treatment with short interfering RNA (siRNA) specific for IRP2) were protected from CSE-induced cell death and from the production of CSE-induced mitochondrial reactive oxygen species (mtROS) 17 ( Supplementary Fig. 8a,b) . Taken together, these data implicate IRP2 as a regulator of CS-induced mitochondrial dysfunction in experimental COPD. Using a Seahorse XF96 apparatus, which provides information on mitochondrial function through real-time measurements of oxygen consumption rate (OCR; a marker of oxidative phosphorylation (OxPhos)) and extracellular acidification (ECAR; a surrogate for glycolysis), we determined the rates and reserve capacity of OxPhos and glycolytic activity in CSE-exposed WT and Irp2 −/− primary lung epithelial cells ( Fig. 3h ). CSE-exposed WT cells had lower OCR:ECAR ratios than RA-exposed cells, indicative of cells shifting energy metabolism from OxPhos to glycolysis. CSE-exposed Irp2 −/− cells had the opposite response in OCR:ECAR ratio, which was characterized by greater levels of OxPhos relative to glycolysis, indicative of enhanced aerobic mitochondrial metabolism with less reliance on glycolysis ( Fig. 3h) . These results suggest that, in lung epithelial cells, IRP2 regulates switching from aerobic (OxPhos) to anaerobic metabolism as an adaptive response to mitochondrial dysfunction ( Fig. 3i) .
IRP2 promotes CS-induced mitochondrial iron loading
Mitochondria are the main consumers of intracellular iron, and a number of vital cellular processes rely on precise mitochondrial iron regulation 29 . Failure to control mitochondrial iron levels leads to mitochondrial iron loss or excessive mitochondrial iron overload, both of which can lead to mitochondrial dysfunction 29 . We wished to investigate whether the observed IRP2-mediated mitochondrial responses to CS ( Fig. 3d-h) were related to IRP2-mediated alterations in mitochondrial iron pathways in the lung.
We first investigated whether CS regulated general iron metabolism in the lung. In body tissues, iron (Fe) is found either as non-heme free iron in the ferric (Fe 3+ ) or ferrous (Fe 2+ ) state or as heme iron (Fe 2+ complexed with protoporphyrin IX) 30 . Consistent with greater Irp2 expression in CS-exposed WT mice, WT mice had higher non-heme iron in inflated lung sections and in whole-lung homogenates than RA-exposed mice ( Fig. 4a) . Whole-lung homogenates of WT mice also had higher and lower expression of the Irp2 target proteins TfR and ferritin, respectively ( Fig. 4b) . Additionally, intracellular free iron was higher in human airway epithelial cells after exposure to aqueous CSE as compared to RA (Supplementary Fig. 8a) . These data suggested that in experimental models of COPD, CS exposure increased iron deposition in the airways of mice. CS-exposed Irp2 −/− mice had similar total non-heme iron levels in whole lung tissue, as compared to CS-exposed WT mice ( Fig. 4c) ; however, staining with Perls' Prussian Blue, which detects ferric iron deposits, revealed less iron deposition in CS-exposed Irp2 −/− mouse lungs than in CS-exposed WT mouse lungs ( Supplementary Fig. 8b ). Furthermore, intracellular free iron levels did not change in CSE-exposed human airway epithelial cells deficient in IRP2 (by treatment with a short hairpin RNA (shRNA) targeting IRP2) ( Supplementary Fig. 8a) .
Once inside the cell, free iron may be delivered to ferritin 30 and iron-containing proteins, or it may be imported into mitochondria for heme or iron-sulfur (Fe-S) cluster biosynthesis. Non-heme and heme iron levels were higher in mitochondrial fractions of WT mouse lungs exposed to CS, as compared to those from RA-exposed controls ( Fig. 4c,d) . Increased mitochondrial iron import is reliant on the use of the inner mitochondrial membrane iron transporter mitoferrin 2 (ref. 31 ). Mitoferrin 2 levels were higher in CS-exposed mice than in RA-exposed controls ( Fig. 4e ), suggesting increased import of iron into mitochondria. Another indicator of increased iron loading, loss of the mitochondrial Fe-S regulator frataxin 32 , was also associated with CS exposure in whole-lung homogenates of WT mice as well as in human airway epithelial cells treated with CSE ( Fig. 4f and Supplementary Fig. 8c ). Ferritin expression was lower in lung tissue from CS-exposed mice than in tissue from RA-exposed mice, but the expression of cytosolic non-heme and heme iron and of the cytosolic iron-binding protein F-box and leucine-rich repeat protein 5 (Fbxl5, also a negative regulator of Irp2 (ref. 21)) was unchanged ( Supplementary Fig. 8d-f ). Additionally, CSE treatment impaired mitochondria and cytosolic Fe-S cluster assembly in human airway epithelial cells ( Supplementary Fig. 8g ). Taken together, these data demonstrate that exposure to CS induced mitochondrial iron loading in experimental COPD.
Irp2 −/− mice were protected from the effects of CS on ferritin and mitoferrin 2 expression, as compared to CS-exposed WT mice ( Fig. 4d,e and Supplementary Fig. 8d ). Irp2 −/− mice were also protected from CS-associated higher mitochondrial non-heme iron and mitochondrial heme iron levels ( Fig. 4d ), suggesting that IRP2 promoted CS-induced mitochondrial iron loading. We have previously shown that heme oxygenase 1 (HO-1), an enzyme that catalyzes the degradation of heme to produce iron, is elevated in CS-exposed mouse lungs and that it may have a protective role in regulating CS-induced mitochondria-mediated cell death 33 . Here we show that the lungs of Irp2 −/− mice had higher baseline levels of HO-, which did not change after CS exposure, than did CS-exposed WT mice ( Supplementary Fig. 8h ), suggesting that the Irp2 −/− mice have more baseline protection from mitochondria-mediated cell death.
To assess whether abnormally increased mitochondrial iron overload is pathogenic in experimental COPD, we evaluated whether mice with higher mitochondrial iron loading (i.e., mice with reduced frataxin expression 32 ) had differential responses to CS exposure in our CS-induced impairment of MCC (bronchitis) mouse model. We chose to use this acute 1-month exposure model to test our hypothesis, as we observed significant differences (P < 0.05) in CS-induced mitochondrial iron loading between WT and Irp2 −/− mice at this time point ( Fig. 4d ). Here we found that mice deficient in frataxin (i.e., mice with a heterozygous transgenic insertion (GAA 230 expansion) of mutated frataxin (knock-in, ki) and a heterozygous deletion of frataxin (knockout, ko); Fxn ki/ko mice) had higher mitochondrial non-heme and heme iron levels, significantly impaired baseline MCC function (P < 0.05) and higher baseline levels of whole-lung IL-6 protein ( Fig. 4g,h ) as compared to WT mice. These data suggest that CS-induced mitochondrial iron loading may be pathogenic in experimental COPD models ( Fig. 4i ).
IRP2 and CS increased lung COX activity and expression
To investigate the mechanism of IRP2-associated mitochondrial iron loading and CS-induced mitochondrial dysfunction, we focused our attention to the mitochondrial genes identified in our RIP-seq study and community-based gene expression analysis (Fig. 3a) . The most significant differentially expressed gene (P < 0.01) in this analysis was COX assembly factor 3 (Coa3), which was expressed at lower levels in Irp2 −/− mice than in WT mice ( Figs. 3a and 5a) . Coa3 encodes coiled-coil domain-containing protein 56 (CCDC56), a mitochondrial protein that stabilizes COX subunit I and promotes its assembly and activity 34 (Fig. 5a) . COX is the terminal electron acceptor of the mitochondrial electron transport chain and is responsible for the npg conversion of oxygen into water. A number of genes encoding other subunits and factors important for COX assembly (such as Cox18 and Cox8A) and mitochondrial OxPhos (including NADH dehydrogenase (ubiquinone) 1 (Nduf) alpha subcomplex, 6 (Nduf66) and Nduf beta subcomplex, 9 (Nduf9) (complex I), succinate dehydrogenase complex, subunit B, iron sulfur (Sdhb) (complex II) and ubiquinolcytochrome c reductase hinge protein (Uqcrh) (complex III)) were also differentially expressed in Irp2 −/− versus WT mice according to this analysis, in addition to other proteins important for mitochondrial integrity and apoptosis ( Fig. 3a) .
It has been proposed that COX acts as a key regulator of mitochondrial iron metabolism 35 . Specifically, COX subunit I is regulated by heme and is the site of iron reduction and transport into mitochondria 35 , where it supplies iron for heme biosynthesis 35 . Consistent with higher Irp2 expression and with altered expression of COX-related mitochondrial genes in WT as compared to Irp2 −/− mice ( Figs. 3a and 5a) , we found that COX expression is higher in lung biopsies from individuals with COPD than in those from control subjects ( Fig. 5a) .
Using an antibody that detects each complex of the mitochondrial electron transport chain, we observed that COX expression was higher in lungs from CS-exposed WT mice than in lungs from CS-exposed Irp2 −/− mice (Fig. 5b) . Irp2 −/− mouse lungs also exhibited less CS-induced reduction in the expression of complexes I and II (Supplementary Fig. 9a ). Expression of the lung-specific isoform of COX (Cox4i2), which renders lung COX twofold more active than COX in other tissues that lack Cox4i2 (ref. 36) , was also higher in CS-exposed WT mice. Irp2 −/− mice had lower Cox4i2 expression than ; CS (4 months), n = 8; CS (6 months), n = 9) and cytosolic (cyto) (RA, n = 6; CS (1 month), n = 11; CS (4 months), n = 3; CS (6 months), n = 5) non-heme iron (right) in WT mouse lungs exposed to RA or CS (n = 2 technical replicates). (d) Quantification of fold changes in non-heme iron (for WT and Irp2 −/− mice: RA, n = 13; CS (1 month), n = 5; CS (4 months), n = 3; CS (6 months), n = 5) (left) and heme iron (for WT and Irp2 −/− ; RA, n = 10, CS-exposed, n = 5 per group) (right) in mitochondrial fractions from mouse lungs exposed to RA or CS (n = 2 technical replicates). (e) Quantification of mitoferrin 2 (Mfn2) expression in whole lungs of mice (for WT and Irp2 −/− : RA, n = 8; CS (1 month), n = 3; CS (4 months), n = 6) after exposure to RA or CS. (f) Quantification of frataxin protein expression in whole lungs of mice exposed to RA or CS for 6 months (WT: RA, n = 5; CS, n = 3; Irp2 −/− : RA, n = 6; CS, n = 6). (g,h) Quantification of mitochondrial non-heme iron (n = 4 per group) (g, left), mitochondrial heme iron (n = 4 per group) (g, right), 3-h 99m Tc-sc clearance (h, left; each circle represents a single mouse, and horizontal lines denote mean) and IL-6 protein concentrations (n = 4 per group) (h, right) in the lungs of WT and Fxn ki/ko mice exposed to RA or CS for 1 month. (i) Schematic of regulation of mitochondrial iron loading by Irp2. Throughout, data are mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001 by one-way ANOVA followed by Bonferroni correction; # P < 0.05, ## P < 0.01, #### P < 0.001 by Student's unpaired t-test; n.s., not significant.
npg WT mice, which did not change after exposure to CS ( Supplementary  Fig. 9b) . Similarly, COX activity was higher in mitochondrial fractions isolated from WT mice that were exposed to CS for 1 month and 4 months, as compared to those from RA-exposed control mice ( Fig. 5c) . COX activity was also higher in mitochondria from CS-exposed WT mouse lungs, but it did not change in mitochondria from CS-exposed Irp2 −/− mouse lungs ( Fig. 5c) . Additionally, CSE-exposed WT lung epithelial cells had greater COX expression and activity than CSE-exposed airway epithelial cells from Irp2 −/− mice (Fig. 5d) .
To examine the function of COX in the response of the lung to CS, we used mice with impaired COX (activity and expression) in our CS-induced bronchitis model. COX is a multi-subunit complex whose assembly requires >20 ancillary factors including that encoded by 'synthesis of cytochrome c oxidase' (SCO2) 37 (Fig. 5a) . By using serial analysis of gene expression (SAGE), we previously showed that SCO2 expression is higher in the lungs of subjects with COPD as compared to the lungs of healthy smokers and non-smokers 38 . Homozygous deletion of Sco2 is embryonic lethal in mice 37 ; however, mice harboring either a Sco2 ki mutation on one allele and a deletion (ko) of Sco2 on the other allele, or two ki mutations, have COX assembly defects and impaired COX activity (with Sco2 ki/ko mice showing more severe COX deficiency than Sco2 ki/ki mice 37 ). We assessed the MCC of Sco2 ki/ko and Sco2 ki/ki mice that were exposed acutely to CS. WT mice had impaired MCC, higher BAL leukocyte counts and higher total BALF protein levels ( Fig. 5e and Supplementary Fig. 9c,d) .
Conversely, Sco2 ki/ko and Sco2 ki/ki mice were protected from left), time course of COX activity (middle) and COX activity after 4 h of exposure (right) in primary lung epithelial cells from WT or Irp2 −/− mice exposed to 20% CSE (n = 2 per group; n = 2 technical replicates). (e) Quantification of 3-h 99m Tc-sc clearance (left), total BALF leukocytes (middle) and total BALF protein levels (right) in WT and Sco2 ki/ko mice exposed to RA or CS for 1 month. Each circle represents one mouse, and horizontal lines denote mean. (f) Quantification of BALF IL-33 (WT: RA, n = 4; CS, n = 5; Sco2 ki/ko : RA, n = 5; CS, n = 4) and BALF IL-6 (WT: RA, n = 4; CS, n = 5; Sco2 ki/ko : RA, n = 5; CS, n = 4) levels for 1 month, using ELISA (n = 3 technical replicates). (g,h) Quantification of total lung non-heme iron (n = 4 per group) (g; n = 3 technical replicates), mitochondrial non-heme iron (n = 3 per group) (h, left) and mitochondrial heme iron (n = 3 per group) (h, right) levels in WT and Sco2 ki/ko mice exposed to RA or CS for 1 month. (i) Schematic of the role of COX Irp2-associated mitochondrial iron loading. Throughout, data are mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.005 by one-way ANOVA followed by Bonferroni correction; # P < 0.05, ## P < 0.01, ### P < 0.005 by unpaired Student's t-test; n.s., not significant.
npg CS-induced loss of MCC (with Sco2 ki/ko showing greater protection than Sco2 ki/ki mice) ( Fig. 5e and Supplementary Fig. 9c ). CS-exposed Sco2 ki/ko mice exhibited lower total BALF levels of IL-6 and IL-33 and lower BAL leukocyte counts than CS-exposed WT mice ( Fig. 5f and Supplementary Fig. 9d) , supporting the hypothesis that increased COX activity confers pathogenicity in experimental COPD.
To determine whether loss of COX resulted in higher levels of mitochondrial iron in a manner similar to that observed with the loss of Irp2, we measured total-lung tissue non-heme iron levels, as well as cytosolic and mitochondrial iron (non-heme and heme) levels, in WT and Sco2 ki/ko mouse lungs exposed to RA or CS (for 1 month). Consistent with the results obtained in WT mice, CS-exposed WT mice had higher total-lung non-heme iron levels as well as higher mitochondrial non-heme and heme iron levels than RA-exposed WT mice (Fig. 5g,h) . Similarly to the Irp2 −/− mice, Sco2 ki/ko mice were protected from CS-associated changes in mitochondrial non-heme iron (Figs. 4d and 5h) . No difference in mitochondrial heme levels or in cytosolic non-heme and heme iron levels was observed in RA-or CS-exposed Sco2 ki/ko mice, as compared to those from WT mice ( Fig. 5h and Supplementary Fig. 9e,f) . These data suggested that Irp2 increased COX, which may be associated with altered mitochondrial non-heme iron in experimental COPD (Fig. 5i) .
Targeting mitochondrial iron in experimental COPD
To test the hypothesis that Irp2 increases mitochondrial iron loading, which leads to mitochondrial dysfunction in experimental COPD, we first assessed whether modulating iron in the diets of WT mice altered responses to CS exposure in our CS-induced bronchitis model. Mice fed a low-iron diet had lower serum and lung non-heme iron levels and were protected from CS-induced MCC impairment (with no effect on weight gain) as compared to mice fed a control iron-replete diet (Fig. 6a,b and Supplementary Fig. 10a ). Mice fed a high-iron diet had higher serum and lung non-heme iron levels, as compared to mice fed a control iron-replete diet, and they showed impaired weight gain at baseline but exhibited similar mucociliary responses to CS exposure as mice fed a control iron-replete diet (Fig. 6a,b and Supplementary Fig. 10a ). We next examined whether alleviating excess mitochondrial iron would alter responses to CS exposure in our CS-induced bronchitis model. Deferiprone (DFP or ferriprox) is an iron chelator that specifically targets mitochondrial non-heme iron deposits and relocates them elsewhere to prevent mitochondrial iron loading 39, 40 . Administration of DFP for the duration of CS exposure protected mice from CS-induced MCC impairment (Fig. 6c) . The protection afforded by DFP treatment was similar to that observed in the Irp2 −/− mice. Administering DFP in an Irp2-deficient background showed synergistic effects, i.e., DFP-treated Irp2 −/− mice had better protection from CS-induced MCC impairment than DFP-treated WT mice or Irp2 −/− mice (Fig. 6c) .
Finally, we evaluated whether mitochondrial iron chelation could alleviate established experimental COPD (pulmonary inflammation and injury) when administered as a therapeutic dosing strategy. WT mice with existing impaired MCC (which develops after 4 weeks of CS exposure) that were treated with DFP during an additional 1.5 or 3 weeks of CS exposure had significantly improved mucociliary clearance (P < 0.05), as compared to mice exposed to CS for the same period of time but without DFP treatment (Fig. 6c) . Similarly, WT mice exposed to CS for 6 or 8 weeks and administered DFP after 4 weeks of CS exposure showed improved weight gain and had lower lung mitochondrial iron loading than mice that were exposed to CS for 6 or 8 weeks but that were not treated with DFP ( Fig. 6d,e ). WT mice with CS-induced pulmonary inflammation and injury (higher BAL leukocyte counts, higher total BALF protein levels, higher BALF IL-33 protein concentration and higher whole-lung tissue IL-6 protein concentration after 4 weeks of CS exposure) that were then treated with DFP during an additional 2 or 4 weeks of CS exposure also showed significant reductions in pulmonary inflammation (BAL total leukocyte counts, and BALF IL-33 and IL-6 protein concentrations) and acute lung injury (total BALF protein) after 2 and 4 weeks of DFP treatment versus mice exposed to CS for the same duration but not treated with DFP (Fig. 6f,g and Supplementary Fig. 10c-e ).
DISCUSSION
GWAS have provided compelling associations for multiple susceptibility loci associated with COPD; most of these loci-including IRP2 (15q25), family with sequence similarity 13, member A (FAM13A) and hedgehog-interacting protein (HHIP)-have been well replicated 3,7,10,41-47 . Here we characterize, for the first time to our knowledge, the functional role of one of these genes, IRP2 (IREB2), in the pathogenesis of COPD. Consistent with increased IRP2 expression in human subjects with COPD 4 , we confirm that Irp2 promotes COPD in two experimental mouse models of COPD.
By using novel experimental approaches and integrating unbiased IRP2 target identification in cells and mouse lungs with human COPD expression data, we demonstrate that IRP2 regulates mitochondriarelated pathways in the lung. We validate this critical regulation in two well-established human COPD cohorts and show a strong association between the differential expression of mitochondrial genes and IRP2 expression in subjects with COPD ( Fig. 6h) . Furthermore, we demonstrate that Irp2 promotes mitochondrial dysfunction in experimental COPD (Fig. 6h) , which may ultimately lead to epithelial cell death and emphysematous destruction associated with COPD 1 . It is probably the case that cells in the lung that rely on mitochondrial function to promote cellular homeostasis may be affected by increased IRP2 expression. These types of cells may include ciliated epithelial cells of the respiratory tract, which rely on mitochondria for ATP generation for efficient ciliary-beat frequency, and parenchymal type II alveolar epithelial cells, which rely on their abundant stocks of mitochondria to regulate surfactant production. These data are consistent with earlier observations that increasing IRP2 is detrimental to cells 48 and mice 21 and that COPD itself is associated with mitochondrial dysfunction and altered mitochondrial dynamics 17, [49] [50] [51] . Further investigations into the valency of the accumulating mitochondrial non-heme iron (i.e., Fe 2+ or Fe 3+ ) and the role of IRP2 in regulating mitochondrial heme biosynthesis will provide important additional insights needed to fully elucidate the role of IRP2 in regulating mitochondrial function in the lung.
Our data showing that IRP2 promotes mitochondrial iron overload in experimental COPD is consistent with previous observations that CS exposure increases iron deposition systemically and in alveolar macrophages from human subjects with COPD 52, 53 . Such iron deposition may also be consistent with recent reports of anemia being associated with poor clinical and functional outcomes in COPD [54] [55] [56] and with reports that systemic inflammation in COPD upregulates serum hepcidin 57 . Excess tissue or, more specifically, excess mitochondrial iron may generate hydroxyl radicals that promote inflammation, cell death and oxidative stress 21 , all of which contribute to the pathogenesis of COPD 1 .
We hypothesize that as a consequence of sustained expression of IRP2, COX increases in airway epithelial cells and may become pathogenic, preceding and leading to mitochondrial dysfunction, epithelial cell damage, inflammation and emphysematous destruction in experimental COPD (Fig. 6h) . In line with our observations, a recent study 36 reported that high COX activity is required for maximal airway responsiveness 36 , and others have shown that COX activity is increased in skeletal muscle from human subjects with COPD 58 . We also illustrate that COX may be a central determinant in the lung for the regulation of mitochondrial iron in response to CS exposure. Consistent with this notion, individuals with mutations in genes that encode subunits of COX have abnormal regulation of iron (sideroblastic anemia 35 ) and defects in mitochondrial heme biosynthesis 59 .
Finally, we highlight the efficacy of therapeutically targeting mitochondrial iron in COPD. Specifically, redistributing excessive mitochondrial iron using the membrane-permeant iron chelator DFP alleviated experimental COPD. This cytoprotective effect of DFP is intriguing given the availability of DFP for human use in the treatment of beta-thalassemia 40 and in various clinical trials. DFP can shuttle iron not only out of mitochondria but also between other cellular organelles, such as nuclei and endosomes, to extracellular apotransferrin. DFP can also mobilize iron from iron-loaded cells and donate it to pre-erythroid cells for hemoglobin synthesis 39, 40 . Mitochondria-independent effects of DFP may therefore account for the synergistic effects of DFP with Irp2 deficiency in our experimental COPD model.
Taken together, these studies provide valuable new insights into the mechanistic role of the COPD susceptibility gene Irp2 in experimental COPD. Our results strongly suggest that IRP2 is one of the potentially multiple COPD susceptibility genes located in the COPD-associated region of chromosome 15q25 identified by GWAS. Although GWAS generate clues to help us identify targets that play important functional roles in the pathogenesis of complex diseases such as COPD, improved integrative approaches for the identification of key genes and functional genetic variants in the GWAS-identified loci are needed. Recent analyses indicate that the IRP2-15q25 locus includes multiple genetic variants simultaneously associated with COPD and npg the expression of nearby genes (COPD eQTLs (expression quantitative trait loci)) 60 ; it is therefore possible that multiple genes located in close proximity to IRP2 (for example, the nicotinic receptors cholinergic receptor, nicotinic, alpha 3 or CHRNA3 and CHRNA5) may influence COPD susceptibility.
Genes, such as IRP2, that are involved in CS-induced stress responses, particularly those converging on the mitochondria, act as first responders in cellular and possibly systemic iron processing which, if sustained for long periods of time, may have deleterious effects at the molecular, cellular and tissue levels, leading to mitochondrial dysfunction and subsequent cell death and the initiation of inflammation that ultimately result in the development of COPD. Finally, our study strongly supports the use of mitochondrial-iron chelators as novel therapeutic approaches for COPD.
METHODS
Methods and any associated references are available in the online version of the paper.
ONLINE METHODS
Animals. Irp2 −/− and WT littermate control mice were from a mixed genetic background consisting of 129S4/SvJae and C57Bl/6 and were from T. Rouault (National Institute of Child Health and Human Development). Sco2 ki/ki (C57BL/6), Sco2 ki/ko (C57BL/6) and WT (C57BL/6) littermate mice were from E. Schon (Columbia University). Sco2 ki/ki mice have a Sco2 knock-in (KI) mutation on both alleles, and Sco2 ki/ko mice have a Sco2 knock-in (KI) mutation on one allele and have Sco2 deleted on the other allele (KO) 37 . Wild-type (C57BL/6) and Fxn ki/ko (C57/BL6) mice were purchased from the Jackson Laboratory. Fxn ki/ko mice harbor one allele of the frataxin (GAA) 230∆neo expansion mutation (Fxn tm1.1Pand ) on one chromosome, and one allele of the frataxin exon 4-deleted mutation (Fxn tm1Mkn ) on the homologous chromosome. All animals were housed in the same room and kept under a 12-h light and dark cycle. The iron content of the standard diet was 200 mg per kg body weight (mg/kg). Power was not explicitly calculated for each experiment. Numbers of mice were typically chosen based on prior experiments. Cages were chosen at random for CS or RA exposures. We did not use a blinded approach during the CS exposure, as mice needed to be monitored during and after smoke exposure. In addition, mouse cages exposed to CS displayed a distinctive smell and color, and were obvious to the investigators. All animal experimental protocols were approved by the Harvard Standing Committee for Animal Welfare and by the Institutional Animal Care and Use Committees of Brigham and Women's Hospital.
In vivo CS exposures, chemical treatments and diet modifications.
We selected age-and sex-matched mice, starting at 6-12 weeks of age, at random and exposed them to total body CS in a stainless steel chamber using a whole-body smoke exposure device (Model TE-10, Teague Enterprises) for 2 h per day, 5 d per week for 4 weeks or 4-6 months. Age-matched male and female mice were used for all CS exposures. Mice were exposed to CS (mainstream and sidestream smoke) from 100 3R4F cigarettes (University of Kentucky), which correlated to an average total particulate matter (TPM) of 150 mg/m 3 . For animals subjected to cigarette smoke exposure, early death was used as an exclusion criterion. At the end of the exposure regimen, we euthanized mice by CO 2 narcosis, cannulated the tracheas and inflated the lungs with PBS at 25 cm of H 2 O pressure. We tied off the left lung with a suture, dissected it and place it into liquid nitrogen. We fixed the right lung in 4% formalin at 4 °C overnight. A proximal portion of the left lung (4-month exposures only) was fixed for transmission electron microscopy (TEM) analysis.
Mice exposed to CS for 4 weeks had modifications to their dietary iron as follows: diet 1 (control diet) from Harlan Laboratories (TD.94045 AIN-93G), which contained 300 parts per million (p.p.m.) iron. Diet 2 (iron-deficient diet) from Harlan Laboratories (TD.10210), which contained 2-6 p.p.m. iron. Diet 3 (iron-replete diet) from Harlan Laboratories (TD.10213), which contained 2% carbonyl iron. Iron diets were exchanged for normal diets upon weaning at 3 weeks of age and used throughout the smoke exposures. We weighed each animal on a weekly basis, and we recorded the quantity of chow consumed, comparing it to that for mice on a normal-iron diet. We administered deferiprone or Ferriprox solution (1 mg/ml) (ApoPharma Inc.) prophylactically in the animals' drinking water for the duration of the smoke exposure. We also administered deferiprone therapeutically in the animals' drinking water, initiating therapy after 4 weeks of smoke exposure and continuing therapy for an additional 2-4 weeks. Animals were checked daily, and the quantity of water consumed was compared to that for control mice. Water solutions were changed twice weekly.
Hyperoxia exposures. We exposed age-and sex-matched Irp2 −/− and WT littermate mice (129S4/SvJae and C57Bl/6 background), starting at 10 weeks of age and selected at random, to hyperoxia (>99% O 2 ) at a flow rate of 12 liters/min in a 3.70-ft3 Plexiglas exposure chamber 61 , with access to chow and water ad libitum. We assessed survival by checking the mice at regular intervals over 0-120 h.
Cecal ligation-puncture (CLP) sepsis model. CLP was done as described 62 . Briefly, under aseptic conditions, we incised the abdominal skin and dissected the abdominal muscles of age-and sex-matched Irp2 −/− and WT littermate mice (129S4/SvJae and C57Bl/6 background), starting at 10 weeks of age and selected at random, to gain access to the peritoneal cavity. We located the mouse cecum and we ligated 75% of it with a 6-0 silk suture and perforated it with a 21 G needle by one through-and-through puncture (two holes) near to the area of ligation. Sham-operated mice underwent the same procedure without ligation and puncture of the exposed cecum. After surgery, we intraperitoneally (i.p.) injected 1 ml of prewarmed (37 °C) normal saline to restore heat and hydration of the operated mice.
Electrophoretic mobility shift assay (EMSA). Irp2 EMSAs were carried out using the LightShift Chemiluminescent RNA EMSA Kit (Thermo Scientific) with a biotinylated IRE, according to the manufacturer's instructions. Supershift assays were carried out using 2.5 µg of anti-Irp2 IgG (NB100-1798, Novus Biologicals).
Immunohistochemistry and immunofluorescence staining. We prepared and stained formalin-fixed, paraffin-embedded 5-µm-thick lung sections using standard procedures. Briefly, sections were deparaffinized through graded alcohols and washed in PBS. Heat-activated antigen retrieval was performed in a microwave oven using a citrate buffer (Target Retrieval Solution, S1699, DAKO) for 10 min. Endogenous peroxidases were blocked using a peroxidase blocker (DAKO Cytomation), and the slides were blocked for nonspecific protein binding by incubating in 10% normal serum for 45 min. Tissues were immunostained with a rabbit primary IgG to Irp2 (LS-B48, LS Bio) at a 1:50 dilution, with mouse anti-cytochrome c, (556433, BD Biosciences) at a 1:250 dilution, with rabbit monoclonal IgG to cytochrome c EPR1327 (D00355 Abcam) at a 1:50 dilution, or with rabbit anti-LC3B (L7543, Sigma-Aldrich) at a 1:400 dilution and signals were developed using the VECTASTAIN Elite ABC Kit (PK-6101; Vector Laboratories), according to the manufacturer's protocol. Hematoxylin and eosin stains were purchased from Sigma-Aldrich, and staining was carried out as per the manufacturer's instructions. The negative control consisted of substituting PBS for the primary antibody.
Epifluorescence microscopy. Briefly, tissues were stained with goat polyclonal IgG to Irp2 (ab106926, Abcam) at a 1:50 dilution or with rabbit monoclonal IgG to Irp2 (ab181153, Abcam) at a 1:50 dilution. Co-staining for type II epithelial cells was carried out using a rabbit polyclonal IgG to prosurfactant protein C (Pro-SPC) (ab90716, Abcam) at a 1:50 dilution and for type I epithelial cells using anti-mouse podoplanin Alexa Fluor 488-conjugated IgG (53-5381-80, Affymetrix) at a 1:500 dilution. Co-staining for Irp2 and markers of ciliated airway epithelial cells was conducted using a rabbit IgG for acetyl-α-tubulin (Lys40) (D20G3, Cell Signaling Technology) at a 1:50 dilution, and co staining for non-ciliated secretory epithelial cells was conducted using a rabbit polyclonal IgG to uteroglobin (ab40873, Abcam) at a 1:100 dilution. Secondary staining was carried out using goat anti-rabbit IgG (H + L) rhodamine red conjugate (R-6394, Life Technologies) at a 1:500 dilution or donkey anti-goat IgG (H + L) secondary antibody-Alexa Fluor 488 conjugate (A-11055, Life technologies) at a 1:500 dilution. Nuclei were counter-stained using TO-PRO-3 Iodide (T3605, Life Technologies) at a 1:1,000 dilution or Hoechst (33342, ThermoFisher Scientific) at a 1:300 dilution.
Morphometric analysis of lung sections.
Formalin-fixed lung samples were cut parasagittally and embedded in paraffin. We performed Modified Gill's staining as described previously 63 . We quantified air-space enlargement using the mean linear intercept (chord)-length (MLI or L m ) method 63 or using a previously published, automated image-processing algorithm that calculates the area-weighted mean diameter or D 2 index 64 . Briefly, randomized images were acquired (Axiophot; Carl Zeiss MicroImaging equipped with a digital camera Axiocam HRc; Carl Zeiss MicroImaging) as black and white TIFF files using a microscope, a 20× objective, and a camera and software that can acquire highquality digital images. 20-30 images (200× magnification) were captured per mouse in a randomized manner, with the observer blinded to the experimental condition, avoiding under-inflated areas of the lung (at 20× magnification). Lung sections were blinded by taping the slide identifiers before acquiring images and before data analysis. Random-number generations using excel and a gridded coverslip were used to choose the sample image area for acquisition in all cases.
npg Mean-chord-length measurements. This protocol measures mean alveolar chord length and alveolar area on paraffin-embedded lung sections stained with Gill's stain. Morphometry software converts images of lung sections to binary images (in which tissue is white and airspace is black), and then superimposes a uniform grid of horizontal and vertical lines (chords), and the software then quantifies the length of each chord within areas identified by the software as airspace 65 . Using this method, it is possible to measure the size of the alveoli in all parts of the lung in a standardized and relatively automated manner 65 . Airspace enlargement was quantified using the MLI method using Scion Image and customized macros to analyze airspace enlargement 65 . Large airways, blood vessels, and other non-alveolar structures were manually removed from the images. The alveolar-chord-length macro was adapted from the macro available in NIH Image. Alveolar chord length for each image was calculated and the average mean chord length ± s.e.m. for each mouse was calculated.
Measurement of alveolar diameters. This protocol measures the area-weighted mean diameter or D 2 index. Compared to the Lm, the D 2 index characterizes the heterogeneity in airspace sizes and has been used in the past to quantify airspace enlargement in many studies [66] [67] [68] [69] [70] , where it has a higher sensitivity and specificity for discerning airspace enlargement in smoke-exposed mice 66 . In this study, the D 2 index was calculated on paraffin-embedded lung sections stained with Gill's stain with randomized image acquisition as described above. The histological images were first thresholded to create a black-and-white image where white pixels correspond to air and black pixels correspond to tissue. To avoid errors associated with non-uniform illumination, each image was split into non-overlapping blocks, and the threshold for each block was calculated using the Otsu's method, which calculates the optimum threshold to minimize the intra-class variance of the black and white pixels 71 . The black-and-white images were then used to calculate a signed distance function where each pixel is assigned the negative of the distance to the nearest black (tissue) pixel. The resulting distance function had a deep minima near the center of each alveolar section and also many shallow local minima close to the alveolar walls created by small local fluctuations in the curvature of the alveolar walls. The shallow minima were removed by a morphological operator called the H minima transform 72 . The resulting modified distance map was then segmented using the watershed algorithm 73 into distinct regions, with each region corresponding to a section of an alveolus. The area occupied by each alveolar section was measured by counting the number of pixels in each region. The measured area was then converted to real units (O (µm 2 ) for mouse alveolar sections) by multiplying with a scaling factor. The area of each alveolar section A was then converted to an equivalent alveolar diameter, d as d = 2 A/p . From the measured equivalent diameters the area-weighted mean diameter D 2 as D d d Small-airway remodeling. We used a modification of a published morphometry method 65, 74 to quantify small-airway remodeling in formalin-fixed lung sections from WT and Irp2 −/− mice exposed to RA or CS for 6 months. Briefly, lung sections were stained with Masson's Trichrome stain (Sigma-Aldrich), and images were acquired using a light microscope (Axiophot; Carl Zeiss MicroImaging) equipped with a digital camera (Axiocam HRc; Carl Zeiss MicroImaging) at 200× magnification by a blinded, experienced reader as previously described 65 .
MetaMorph software (Molecular Device LLC) was used to measure the mean airway luminal diameter and the thickness of the sub-epithelial fibrosis layer stained blue by Masson's Trichrome stain at 12 separate sites around the airway by a different blinded, experienced reader. The mean (±s.e.m.) thickness of the sub-epithelial layer in microns was calculated for airways having a mean internal diameter between 300 and 699 µm. Sections of airways sharing their adventitia with arteries or other airways were not included in the analysis.
BALF isolation, cell counts and ELISA. Mice were euthanized by CO 2 narcosis, the tracheas cannulated and the lungs lavaged with 0.5-ml increments of ice-cold PBS eight times (4 ml total). BALF was centrifuged at 500g for 5 min. 1 ml red blood cell lysis buffer (Sigma-Aldrich) was added to the cell pellet and left on ice for 15 min followed by centrifugation at 600g for 3 min. The cell pellet was resuspended in 500 µl PBS, and leukocytes were counted using a hemocytometer. Specifically, 20 µl was removed for cell counting (performed in triplicate) using a hemocytometer, and 80 µl was removed for cytocentrifuge preparations (Shandon Cytospin3, 300 r.p.m. for 5 min) and stained using the Hema3 staining system (Fisher Scientific). The percentages of macrophages, lymphocytes and polymorphonuclear leukocytes (PMNs) were counted in a total of 300 cells, and absolute numbers of each leukocyte subset were calculated. Commercial ELISAs were used to measure the following analytes in duplicate in homogenates or BALF of lung samples from mice following the manufacturer's instructions: MMP-9 (Mouse Total MMP-9 DuoSet, DY6718, R&D Systems), cleaved caspase-3 (Human/Mouse Cleaved Caspase-3 (Asp175) DuoSet IC, R&D Systems DYC835-2), IL-6 (mouse IL-6 DuoSet, R&D Systems DY406), IL-33 (mouse IL-33 DuoSet, R&D Systems DY3626-05), IL-18 (IL-18/IL1F4 ELISA kit 7625, R&D Systems) and IL-1β (Mouse IL-1β/IL-1F2 R&D Systems DY401-05).
Assessment of mucociliary clearance. Mucociliary clearance was quantified using a non-invasive, oropharyngeal aspiration procedure described previously 18 . Briefly, we anesthetized mice and introduced 50 µl of normal saline containing approximately 0.3-0.5 mCi of 99m Technetium sulfur colloid ( 99m Tc-sc) (Brigham and Women's Hospital) into the distal part of the oropharynx by aspiration. We immediately imaged mouse lungs after aspiration (t = 0 h) and at 1 h and 3 h. Whole-mouse three dimensional (3D) micro single-photon emission computed tomography (µ-SPECT) images from 10-min acquisitions at 0-, 1-, and 3-h time points were obtained, reconstructed, blindly analyzed and expressed as the percentage removed by mucociliary clearance. Regional lung deposition of 99m Tc-sc, characterized by calculating the central (area closest to the trachea) to peripheral airway distributions ratio (C:P ratio), was corrected for, as described previously 75 . To correct for any abnormality in distribution, MCC rates were corrected for C:P differences using standard multi-variable linear regression 76 .
RIP-seq. Three 15-cm 2 dishes (1.5 × 10 6 cells) of Beas2B cells (purchased from ATCC), treated with or without 10 µM DFO (16 h), were washed with ice-cold PBS and collected into 2-ml microcentrifuge tubes by scraping. We carried out RNA immunoprecipitation using the Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore). 4 µg of mouse Irp2 IgG (7H6: sc-33682, Santa Cruz) or 4 µg of IgG mouse control antibody (sc-2749, Santa Cruz) were added to supernatants and incubated overnight at 4 °C. We extracted RNA from Magna RIP beads by Trizol extraction. Samples (n = 2 biological replicates) were prepared for RNA-seq using the TruSeq RNA-seq Lib Prep Reagent (Illumina), and sequencing was performed on the Illumina HiSeq2000 platform. Sample preparation and sequencing was carried out by The Center for Cancer Computational Biology, Dana-Farber Cancer Institute, Boston, MA (http:// cccb.dfci.harvard.edu). RIP-seq data (GEO accession number GSE57073) was analyzed as follows. Sequenced reads for two biological replicates each in control (Ctl) and DFO samples, as well as Ctl-IgG and DFO-IgG, were aligned to the human hg19 known transcriptome using bowtie2-2.0.6 and tophat-2.0.7.Linux_x84_64. Any unmapped reads were then allowed to map to the hg19 genome. Aligned reads were then combined from replicates and the HOMER algorithm (http://homer.salk.edu/homer/ngs/index.html) was used to identify and annotate 'peaks' , or regions enriched for reads in one sample compared to another. Peak-calling was performed on the aligned reads, resulting in the identification of 3,497 'common' peaks (mapping to 1,806 genes) that were shared between the control (Ctl) and DFO samples as well as Ctl-specific peaks and DFO-specific peaks. Validation of our data included the detection of peaks in known IRP2 targets, including ferritin and TfR ( Supplementary  Fig. 4e,f) . We also estimated the percentage of peaks with the known IREbinding motif (CAGWGH) 77 .
Four primary comparisons were made: Ctl compared to Ctl-IgG (Ctl/IgG), DFO compared to DFO-IgG (DFO/IgG), Ctl compared to DFO (Ctl/DFO) and DFO compared to Ctl (DFO/Ctl). The first two comparisons identified where IRP2 is bound in either Ctl or DFO samples, whereas the latter two comparisons highlight where IRP2 is uniquely bound in only the Ctl or DFO sample (Supplementary Fig. 4d ). In each comparison a peak was associated with a genomic region if that peak had a twofold enrichment of the tag relative to the input sample, a Poisson P < 0.1 and a peak-score (position-adjusted read counts) greater than 5.
npg
To build a robust set of peaks for further analysis, we identified peaks common between the different comparisons using HOMER's 'mergePeaks' function. 3,497 common peaks (where IRP2 is bound in both Ctl and DFO) were identified as shared between the Ctl/IgG and DFO/IgG comparisons. Ctl-specific peaks and DFO-specific peaks were identified by determining peaks common to the Ctl/IgG and Ctl/DFO or the DFO/IgG and DFO/Ctl comparisons, respectively ( Supplementary Fig. 4d ). For peaks belonging to one of these three sets, we used HOMER's 'annotatePeaks' function to scan the genomic sequence of the peak regions for the known IRE-binding motif (CAGWGH) 77 and to map peaks to their target genes. Common peaks mapped to 1,806 unique gene transcripts and Ctl-specific and DFO-specific peaks mapped to 2,203 and 2,135 unique gene transcripts, respectively (Supplementary Fig. 4d ).
Gene expression microarray analysis. The GeneChip Mouse Gene 1.0 ST Array (Affymetrix) was used to assess gene expression in the Irp2 −/− and WT mice. RNA was isolated from lungs harvested from WT age-matched (n = 3 males and 3 females) and Irp2 −/− (n = 3 males and 3 females) using the RNeasy Mini Kit (Qiagen). The gene expression data GEO accession number GSE57048 was analyzed as follows. GSE57048 was robust multiarray average (RMA)-normalized, and probe sets were mapped to EntrezGene IDs using a custom Chip Definition Files (CDF) 78 . To compare the expression data to the RIP-seq data, we selected 16,573 genes on the expression array that belong to a single conserved homologous group (http://www.ncbi.nlm.nih.gov/homologene/) with the corresponding human homolog identified. For these genes the expression difference between the Irp −/− and WT mice was quantified using an unpaired two-tailed t-test.
Functional enrichment clustering analysis. To evaluate how IRP2 may affect the activity of cellular pathways in the lung, we carried out functional enrichment analysis using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) 79 tool 79, 80 . DAVID analysis (http://david.abcc.ncifcrf.gov) was carried out on the genes in each of three RIP-seq-defined sets (Ctl, DFO and common), both independently and combined. To better interpret the results of this analysis, the fast-greedy community-structure algorithm 81 was applied to a network defined by the GO annotations between the genes identified in the RIP-seq analysis and the GO terms identified as enriched (false-discovery rate (FDR) < 1 × 10 −3 ) in the DAVID analysis on the combined gene set. This network analysis resulted in the identification of five communities containing related sets of genes and terms (Supplementary Fig. 4g ). For each community identified in the RIP-seq data, the values of the t-statistic for genes in the community was compared to those not in the community, and a 'meta'-t-statistic and associated P value was computed, representing the significance of the association of the Irp2 −/− versus WT differentially expressed genes with genes in each of the RIPseq communities 82 (Fig. 2b) . This analysis revealed a strong association between differentially expressed genes and genes in community 2.
Next we selected the genes belonging to community 2 that are also strongly differentially expressed (P < 0.01) in Irp2 −/− mice, as compared to WT mice. We examined to which GO categories (Gene Ontology terms 83 ) these genes are annotated and made three heat maps ( Fig. 3a and Supplementary Fig. 5 ) based on whether they are annotated to mitochondrial functions (Fig. 3a) , protein localization functions (Supplementary Fig. 5a ) or other functions that belong to community 2 (Supplementary Fig. 5b) . In each heat map, the rows were zscore-normalized to aid in visualizing differences in expression values.
Because RIP-seq was based on a specific IRP2 antibody that immunoprecipitated IRP2-mRNA complexes only (subtracting IgG-mRNA complexes as background) and then was followed by a comparison to the baseline gene expression in WT versus Irp2 −/− lungs, the effects of DFO are therefore not confounded on the functional enrichment clustering analysis carried out in this study, and the results are related to IRP2 only. Specifically, 83% (34 of 41) of the genes we show in Figure 3a were identified as a target of IRP2 in the Ctl versus IgG comparison (so they were in the common peaks, the CTRL-only peaks, or both). Only seven genes were identified in the DFO-only peak set. Circos plot generation. By using the DAVID output from the combined geneset analysis, a Circos plot was generated to graphically demonstrate the gene transcripts and pathways enriched and/or altered in our Ctl-specific (blue), DFO-specific (red) and common (purple) data sets. The inner ring of the Circos plot is colored to represent the five identified functional communities. Because each gene belongs to only one community, genes were assigned to segments of the circle located within their community. Other genomic information associated with these genes, such as COPD differential expression and RIP-seq peak scores, was then visualized on different 'rings' aligned over these genes.
LGRC gene expression (mRNA) Circos plots. To identify any common pathways that may be dysregulated by IRP2 in subjects with COPD, we included gene expression data (mRNA) (Fig. 2a) from lung tissue of individuals with COPD and those from controls from the Lung Genomics Research Consortium (LGRC; http://www.lung-genomics.org) on the Circos plot. The Lung Genomics Research Consortium used lung tissue samples from the Lung Tissue Research Consortium and was funded by the National Heart, Lung, and Blood Institute. Lung tissue mRNA expression data was downloaded from the publicly available LGRC data set GSE47460. This 159-mRNA gene expression data set contained data from n = 121 individuals with COPD, n = 20 non-smokers and n = 18 smokers. We calculated the fold-change difference between the expression values for each gene in the COPD versus control samples; the inner ring (black ring) of the Circos plot shows the fold change for genes containing an identified IRP2 peak. Genes with fold changes of more than 1.5 or less than 1/1.5 were highlighted (green denotes lower than COPD, magenta denotes higher in COPD). Circos-plot generation allowed for the visualization of similarities and differences between the Ctl (blue), DFO (red) and common (purple) RIP-seq peak sets and human COPD RNA-seq (black).
Phenotypic characterization of emphysema and source of tissue. The
LGRC provides genetic, molecular, and quantitative phenotype data as well as exclusion criteria, for human subjects in the NHLBI's Lung Tissue Research Consortium (LTRC) biorepository (http://www.lung-genomics.org). Lung tissue samples were collected as part of the routine care of patients and submitted with a standardized series of questions. In addition to standard spirometry, DLCO (diffusing capacity of the lungs for carbon monoxide) data were available. For controls, we included only individuals with a DLCO greater than 80%, and for test cases the DLCO was less than 80%.
As previously mentioned, the LGRC mRNA gene-expression data set used the publicly available GSE47460 data set. The 159-mRNA gene expression data set contained data from n = 121 individuals with COPD, n = 20 non-smokers and n = 18 smokers with phenotypic information along with LTRC overall final pathologic diagnosis (CPAL1) is presented in Supplementary Table 2 .
Distributional location of the lung tissue resection (right or left, upper or lower lobe), along with pathological diagnosis is presented in Supplementary  Table 3 .
Validation of mitochondrial genes in two COPD cohorts.
To compare the mitochondrial genes in human COPD lung tissue with high or low IRP2 expression that we identified, we used two independent COPD cohort data sets of gene expression.
COPD data set 1. We used publicly available gene expression data from the LGRC (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47460). Data collected using each of the two array platforms included was backgroundcorrected and then normalized between arrays using limma 84 . Next we removed duplicate probes and then merged the two array platforms by matching probes that shared the same gene name. This merged data set was then corrected for array-specific batch effects using ComBat 85 . Of the 580 subjects included in this publicly available data, we identified those with a COPD diagnosis or a control status (219 and 107 individuals, respectively). Approximately half of these subjects were subsequently removed based on quality control, leaving us with a 159-subject mRNA gene-expression data set contained (n = 121 COPD, n = 20 non-smokers and n = 18 smokers). In this final data set, all subjects with COPD had a DLCO less than 80%, and all controls (both smokers and non-smokers) had a DLCO greater than 80%.
COPD data set 2. We also used gene expression data from the ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points) study. This study was a 3-year observational study 86 , where emphysema-predominant COPD was defined by >10% of lung voxels with attenuation ≤ −950 HU (Hounsfield units) on inspiratory chest CT scans.
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Other assessments include pulmonary function measurements (spirometry, impulse oscillometry, chest computed tomography, biomarker measurement (in blood, sputum, urine and exhaled breath condensate), health outcomes, body impedance, resting oxygen saturation and 6-min walking distance 86 ). CEL expression files from ECLIPSE (GSE54837), with phenotype information, was downloaded from GEO (http://www.ncbi.nlm.nih.gov/geo/geo2r/ ?acc=GSE54837) 86 . This particular data set contained n = 136 COPD subjects, n = 84 smoker controls, n = 6 non-smoker controls. The ECLIPSE data was RMA-normalized using a custom CDF.
Raw expression data from the two COPD cohorts was downloaded, including raw data files (.TAR) from LGRC (GSE47460), and CEL expression files from ECLIPSE (GSE54837); the ECLIPSE data was RMA-normalized using a custom CDF. We identified which of our selected mitochondrial genes (Fig. 3a) were measured in each of these cohorts and showed their expression levels in ECLIPSE and LGRC (Fig. 3b,c and Supplementary Fig. 6 ) within different subject populations. In each heat map, the subjects are ordered (from left to right) based on increasing values of IRP2 gene expression, with a white bar delimiting which individuals were identified as having low IRP2 expression (less than the median across all subjects) or high IRP2 expression (greater than the median across all subjects). Rows are ordered the same as Figure 3a and each row is z-score-normalized for visualization purposes (Supplementary Fig. 6 ).
For the LGRC gene-expression data set, the overall 'meta' P values (for the genes in the heat map) were: COPD subjects: 1.4 × 10 −3 ; smoker controls: 0.9564; non-smoker controls: 0.5303 (Supplementary Fig. 6a ). For the ECLIPSE data set, the overall meta P values (for the genes in the heat map) were: COPD subjects: 1.4088 × 10 −7 ; smoker-controls: 6.1838 × 10 −3 ; non-smoker controls: 1.6108 × 10 −5 (Supplementary Fig. 6b) . In all cases the overall differential expression is consistent with observations in the Irp2 −/− versus WT mice (overall decreased expression of these genes in low IRP2 as compared to high IRP2, corresponding to more green on the left of the heat maps.
Finally, we also compared our results with a study published earlier that defined a 127-gene expression signature associated directly with increases in L m from microCT information of COPD subjects as reported by Campbell et al. 87 . While IRP2 was not enriched in the 127-gene expression list in Campbell et al. 87 , it had an FDR of <1 (0.63) and a t-statistic of −1.44. On this list, IRP2 (IREB2) was ranked 2,475 (out of 17,879), based on the fold change value, and 2,282 (out of 17,879), based on the t-statistic value. When we examined the 127-gene expression signature from Campbell et al. for gene targets that were common to our RIP-seq study, we noted that 114 of the genes in this expression signature were included in the annotations used by HOMER, when mapping our peak calls. Of these 114 genes, 27 had an identified IRP2 peak in our data, an overlap that is marginally significant (P = 0.06, Fisher's Exact test). When investigating the three sets of peaks separately (CTRL, DFO, and common), there was a strong significant overlap (18 genes, P = 1.6 × 10 −3 ) between the 127 genes in the expression signature and the genes that had common peaks of IRP2. Furthermore, within the set of 27 genes in the gene expression signature that also had an identified IRP2 peak, there was a relative enrichment for genes with decreased expression with increased emphysema severity (21/27 or 78% of genes in the expression signature that have an IRP2 peak have decreased expression with increased emphysema severity, as compared to 73/114 or 64% of all genes in the full expression signature). This was highly driven by genes with peak calls in the DFO experiment; all 12 genes in the gene-expression signature that had a DFO peak were found to have decreased expression levels with increased emphysema severity.
Human samples and study approval. Human lung tissues were analyzed under the guidelines of Brigham and Women's Hospital Institutional Review Board (IRB) approval. Human samples were classified based on the guidelines of the Global Initiative for Obstructive Lung Disease (GOLD2) as previously described 17, 18, 22 . Human samples obtained from the Lung Genomics Tissue Research Consortium (LTRC) used in Figure 5a were homogenates from GOLD2 tissues obtained from open lung biopsies and are described in Supplementary  Table 4 (adapted from Lam et al. 18 ). The Lung Genomics Research Consortium (LGRC) provides genetic, molecular, and quantitative phenotype data for human samples in the National Heart, Lung and Blood Institute LTRC biorepository (http://www.lung-genomics.org). Informed consent was obtained from all subjects included in these studies.
Transmission electron microscopy (TEM). Tissues from mice exposed to chronic CS were fixed overnight at 4 °C using TEM-grade fixative solution of 2% formaldehyde and 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4. The samples were washed and stored in 0.1 M sodium cacodylate buffer and kept at 4 °C until processing. Sample embedding was performed using a standard protocol as previously described 18 . For EM quantification, 15 image fields were selected at random by a blinded reader for each mouse or sample (n = 1 mouse per group). Specifically, a blinded code was generated by the TEM core facility and images were acquired by an experienced core facility technician. S.M.C. analyzed slides using a blinded key. The total area of the cytoplasm was calculated, and the number of mitochondria with 'abnormal' characteristics (defined as mitochondria with swollen or abnormal cristae) per unit area of cytoplasm were counted using ImageJ (NIH).
Cell culture, siRNA, shRNA and CSE. Primary epithelial cells were isolated from mouse lungs as previously described and used for experiments before passage 17 . Primary human bronchial epithelial (HBE) cells were obtained from the American Type Culture Collection (ATCC) and were cultured according to ATCC's instructions. Human lung bronchial epithelial Beas-2B cells were purchased from ATCC and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS and gentamicin (100 µg/ml). Beas2B and HBE cell lines were authenticated and checked for mycoplasma infection. Beas2B cells were treated with siRNA targeted to human IRP2 (SMARTpool: ON-TARGETplus IREB2 siRNA L-022281, Dharmacon, GE Healthcare) for 48 h using Lipofectamine RNAiMAX Transfection Reagent (Life Technologies) using standard transfection techniques. shRNA targeted to human IREB2 was from Sigma-Aldrich (NM_004136, iron-responsive element-binding protein 2 MISSION shRNA). MISSION shRNA clones in shRNA lentiviral plasmids (pLKO.1-puro) were purchased as frozen bacterial glycerol stocks in Escherichia coli for propagation and downstream purification of the shRNA clones. shRNA viral particles were generated using standard procedures, and cells containing positive shRNA clones were selected for using puromycin.
CSE was prepared and added to culture media as previously described 63, 88 . Briefly, a peristaltic pump (VWR International) was used to bubble mainstream smoke from five 3R4F cigarettes with filters removed through 50 ml DMEM. Each cigarette was smoked within 6 min until approximately 17 mm remained. The extract was filter-sterilized, stored at −80 °C, and used immediately upon thawing. The CSE generated in this fashion was considered to be at 100% strength and was diluted in complete DMEM medium for cell treatment.
Measurement of mitochondrial membrane potential and cytochrome c oxidase activity. Mitochondria-enriched fractions were isolated from the lungs of mice and JC1 uptake was measured by using the MITOISO1 mitochondrial isolation kit (Sigma-Aldrich). Mitochondrial membrane potential was measured in primary epithelial cells using tetramethylrhodamine ethyl ester (TMRE) (Abcam). Briefly, cells were treated with CSE or 20 µM carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) for the indicated times and stained for 20 min at 37 °C with 150 nM TMRE. Data were acquired with a FACSCanto II (BD Biosciences) and analyzed with FlowJo analytical software (Tree Star Inc.). Cytochrome c oxidase activity was measured in mitochondria-enriched fractions using an optimized colorimetric assay based on the decrease in absorbance of ferrocytochrome c measured at 550 nm, which is caused by its oxidation to ferricytochrome c by cytochrome c oxidase (Sigma-Aldrich).
Seahorse analysis. Extracellular acidification rates and oxygen consumption rates were determined by the Seahorse XF 96 flux analyzer (Seahorse Bioscience). Primary airway epithelial cells were isolated as described above and plated onto cell culture microplates (Seahorse Bioscience) coated with 50 ng/µl laminin 1 (3400-010-01, Trevigen) for 4 d (with medium change on day 2). On the day of the experiment, cells were treated with CSE for 4 h. Cells were incubated in XF assay medium (Seahorse Bioscience), supplemented with 5 mM glucose, 4 mM glutamine and 1 mM pyruvate for 1 h before the measurement. After the recording of the basal rates of ECAR and OCR, final concentrations of 1 µM npg
